pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›ZINC
drug
save

ZINC

updated 3mo ago
by HOSPIRA
community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying ZINC

  • phase3Comparative Efficacy of Different Dentin Occluding Toothpaste Technologiesrecruitingn=132
  • phase2Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinibactive not recruitingn=305
  • phase4Evaluate the Efficacy of an Oral Health Behavioral Intervention in People With Diabetesenrolling by invitationn=10,000
  • phase3Investigation of Colgate Dual Zinc Toothpaste as Compared to Colgate Cavity Protection Toothpaste in Controlling Plaque and Gingivitiscompletedn=86
  • phase3Effect of Mouthwash in Reducing the Symptoms Associated With Flu and Cold Virusescompletedn=150
  • phase3Efficacy of a Stannous Fluoride Toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reducing Established Dental Plaque and Gingivitis.recruitingn=135
  • N/AZinc Supplementation and Infections in Older Medical Patientsnot yet recruitingn=8,000
  • phase3Investigation of Clinical Efficacy of a New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems as Compared to a Control Mouthwashactive not recruitingn=80
more trials →

News(5)

  • PTC takes a chance on Sangamo’s Fabry disease gene therapy
    Wall Street analysts view the deal as a risky, high-reward bet on a treatment that’s nearing a possible regulatory approval and could be superior to existing medications.
    biopharma_dive · 2h ago
  • Bankrupt Sangamo offloads assets to Lilly, PTC in $161M sale
    PTC Therapeutics emerged as the winning bidder over Astellas for Sangamo Therapeutics’ Fabry disease gene therapy, while Eli Lilly is purchasing the biotech’s prion disease program and several plat…
    biospace · 6h ago
  • PTC’s $211M bid wins Sangamo auction, teeing up ‘special opportunity’ to enter Fabry market
    PTC Therapeutics has struck a deal to buy Sangamo Therapeutics’ Fabry disease program for $111 million upfront, outbidding Astellas and TerSera Therapeutics for the near-approval gene therapy. Sang…
    fiercebiotech · 9h ago
  • How supplement use changed over decades
    Medicare-funded weight loss, Utah's lower drunk driving limit, and more health news from Morning Rounds
    stat · 1mo ago
  • FDA OKs first new sunscreen ingredient in more than 25 years
    Federal health regulators on Tuesday signed off on the first new sunscreen ingredient for the U.S. market in more than 25 years.
    stat · 2mo ago
brand
ZINC
generic
ZINC CHLORIDE
Data sources
ClinicalTrials.gov
last refreshed 19m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?